Surgery Websites
Department of Surgery »  Faculty »  Transplant Surgery  »  Ryutaro Hirose, M.D.
Ryutaro Hirose, M.D.

Ryutaro Hirose, M.D.

Professor of Clinical Surgery 
Division of Transplant Surgery
Associate Program Director,
UCSF General Surgery Residency Program
Surgical Medical Director, SRTR

Contact Information

(415) 353-1888 Clinical, Liver
(415) 353-1551 Clinical, Kidney and Pancreas
(415) 353-8783 Academic
Ryutaro.Hirose@ucsfmedctr.org   
Open Popup
  • Columbia College, Columbia University, B.A., Mathematics, 1981-85
  • Columbia University College of Physicians And Surgeons, M.D., 1985-89
  • University of California, San Francisco, Intern and Resident, Surgery, 1989-92
  • University of California, San Francisco, Resident, Surgery, 1995-96
  • University of California, San Francisco, Chief Resident, Surgery, 1996-97 
  • University of California, San Francisco, Fellow, Transplant Surgery, 1997-99
  • University of California, San Francisco, Postdoctoral Fellow, Molecular Medicine, 1992-95
  • American Board of Surgery, 1998
  • Bile Duct Cancer (Cholangiocarcinoma)
  • Bile Duct Injuries
  • Bile Duct Strictures
  • Complex Cancer Resections
  • Fulminant Hepatic Failure
  • Hepatitis B
  • Hepatitis C
  • Hepatocellular Carcinoma (Liver Cancer)
  • Kidney Transplantation
  • Liver Resection
  • Liver Transplantation
  • Living Donor Kidney Transplantation
  • Living Donor Liver Transplantation
  • Pancreas Transplants
  • Pediatric Kidney Transplantation
  • Pediatric Liver Transplantation
  • Portal Hypertension
  • Radio Frequency Ablation (RFA)
  • Surgical Shunts
  • Ischemia Reperfusion Injury in Fatty Livers
  • Ischemia-reperfusion Injury in Kidneys and Hyperglycemia
  • Living Donor Liver Transplantation
  • Non-melanoma Skin Cancer in Organ Transplant Patients
  • Outcomes in Renal Transplant Recipients
  • Pathogenesis of Focal Segmental Glomerulosclerosis

Ryutaro Hirose is a Professor of Clinical Surgery at UCSF and performs liver, kidney and pancreas transplants. After graduating from Columbia College of Physicians and Surgeons, he completed his clinical and research training at UCSF as a resident in general surgery as well as a fellow in molecular medicine and transplantation surgery. His research interests include renal and hepatic ischemia - reperfusion injury, immune monitoring and skin cancer in transplant recipients. He has received funding from the NIH, NKF, UCSF, ASTS, and private industry. He is also actively involved with teaching students and residents. Dr. Hirose is currently the Associate Program Director for the General Surgery Residency at UCSF. In 2019, Dr. Hirose was appointed Surgical Medical Director of the  Scientific Registry of Transplant Recipients (SRTR).

Dr. Hirose's research focus is ischemia-reperfusion injury and potential interventions to ameliorate renal and hepatic I-R injury. His group uses animal models, performs clinical and translational research as well as research on deceased donors. He collaborates with Dr. Claus Niemann, MD from the Dept. Anesthesia and they are co-Directors of the Ischemic Organ Injury Lab.

MOST RECENT PUBLICATIONS FROM A TOTAL OF 85
Publications provided by UCSF Profiles, powered by CTSI.
  1. Jain M, Duh QY, Hirose R, Sosa JA, Suh I. A model for the institutional adoption of innovative surgical techniques. Surgery. 2020 May 03. View in PubMed
  2. Snyder JJ, Musgrove D, Zaun D, Wey A, Salkowski N, Rosendale J, Israni AK, Hirose R, Kasiske BL. The Centers for Medicare and Medicaid Services' proposed metrics for recertification of organ procurement organizations: evaluation by the Scientific Registry of Transplant Recipients. Am J Transplant. 2020 Mar 11. View in PubMed
  3. Vagefi PA, Bertsimas D, Hirose R, Trichakis N. The rise and fall of the model for end-stage liver disease score and the need for an optimized machine learning approach for liver allocation. Curr Opin Organ Transplant. 2020 Apr; 25(2):122-125. View in PubMed
  4. Roll GR, Posselt AM, Freise J, Baird J, Syed S, Mo Kang S, Hirose R, Szot GL, Zarinsefat A, Feng S, Worner G, Sarwal M, Stock PG. Long-term follow-up of beta cell replacement therapy in 10 HIV-infected patients with renal failure secondary to type 1 diabetes mellitus. Am J Transplant. 2020 Jan 28. View in PubMed
  5. Brondfield MN, Dodge JL, Hirose R, Heimbach J, Yao FY, Mehta N. Unfair Advantages for Hepatocellular Carcinoma Patients Listed for Liver Transplant in Short-Wait Regions Following 2015 Hepatocellular Carcinoma Policy Change. Liver Transpl. 2020 May; 26(5):662-672. View in PubMed
  6. View All Publications
  • Alfonso Garcia

    A Young Man Saves Teen's Life

    Alfonso Garcia was just like any other typical healthy and active 16-year-old. He dreamed of attending the U.S. Military Academy at West Point, boxing, and serving in the military like his two other brothers. Then, in January 2010, he suddenly started feeling sick. He became feverish, anemic, fatigued and jaundiced. Alfonso found out that he had Wilson's disease, a rare genetic disorder in which copper in the body isn't properly eliminated and instead accumulates, damaging the liver and nervous system. Alfonso and his family received a grave[...]
    Story Categories: Liver TransplantWilson Disease

 

Site Directory
    X